Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma

被引:23
作者
Wu, Wen-Jie [1 ]
Shi, Jia [1 ]
Hu, Gang [2 ]
Yu, Xin [2 ]
Lu, Han [3 ]
Yang, Ming-Liang [4 ]
Liu, Bin [2 ]
Wu, Zhi-Xiang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Surg, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China
[2] Hubei Polytech Univ, Coll Med, Key Lab Kidney Dis Pathogenesis & Intervent Hubei, Huangshi 435003, Hubei, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Anesthesiol, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China
[4] Jianli Second Peoples Hosp, Dept Anesthesiol, Jianli 433325, Hubei, Peoples R China
关键词
Hepatocellular carcinoma (HCC); FBXW7; MicroRNA-770; Wnt/beta catenin; TUMOR-SUPPRESSOR GENE; UBIQUITIN LIGASE; CYCLIN-E; F-BOX; CANCER; FBW7; DEGRADATION; MYC;
D O I
10.1007/s13277-015-4452-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FBXW7 (F-box and WD repeat domain-containing 7) is the F-box protein component of a Skp1-Cul1-F-box protein-type (SCF-type) ubiquitin ligase. Previous studies have shown that FBXW7 serves as a tumor suppressor and is frequently downregulated in many types of human neoplasms. However, the molecular mechanisms for its downregulation remain poorly understood. Hyperactivation of Wnt/beta-catenin signaling pathway is viewed as crucial for tumorigenesis, including hepatocellular carcinoma (HCC). In the present study, we show that protein levels, but not message RNA, of FBXW7 were suppressed by Wnt3a treatment or transfection of a constitutively activated beta-catenin in HCC cells. Besides, microRNA-770 was identified as an important downstream target of Wnt/beta-catenin signaling, to inhibit FBXW7 expression through targeting its 3'-untranslated region. Thus, our results suggest a previously unknown Wnt/beta-catenin-miR-770-FBXW7 molecular network in the HCC development.
引用
收藏
页码:6045 / 6051
页数:7
相关论文
共 28 条
  • [1] WNT signalling pathways as therapeutic targets in cancer
    Anastas, Jamie N.
    Moon, Randall T.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (01) : 11 - 26
  • [2] The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis
    Balamurugan, Kuppusamy
    Wang, Ju-Ming
    Tsai, Hsin-Hwa
    Sharan, Shikha
    Anver, Miriam
    Leighty, Robert
    Sterneck, Esta
    [J]. EMBO JOURNAL, 2010, 29 (24) : 4106 - 4117
  • [3] Bochis OV, 2015, J GASTROINTEST LIVER, V24, P225, DOI 10.15403/jgld.2014.1121.242.skp2
  • [4] MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer
    Calcagno, Danielle Queiroz
    Freitas, Vanessa Morais
    Leal, Mariana Ferreira
    Teixeira de Souza, Carolina Rosal
    Demachki, Samia
    Montenegro, Raquel
    Assumpcao, Paulo Pimentel
    Khayat, Andre Salim
    Cardoso Smith, Marilia de Arruda
    Ribeiro dos Santos, Andrea Kely Campos
    Burbano, Rommel Rodriguez
    [J]. BMC GASTROENTEROLOGY, 2013, 13
  • [5] miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes
    Dweep, Harsh
    Sticht, Carsten
    Pandey, Priyanka
    Gretz, Norbert
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2011, 44 (05) : 839 - 847
  • [6] Gong J, 2015, TUMOUR BIOL
  • [7] hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53
    Kimura, T
    Gotoh, M
    Nakamura, Y
    Arakawa, H
    [J]. CANCER SCIENCE, 2003, 94 (05): : 431 - 436
  • [8] Ubiquitin-mediated control of oncogene and tumor suppressor gene products
    Kitagawa, Kyoko
    Kotake, Yojiro
    Kitagawa, Masatoshi
    [J]. CANCER SCIENCE, 2009, 100 (08): : 1374 - 1381
  • [9] Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase
    Koepp, DM
    Schaefer, LK
    Ye, X
    Keyomarsi, K
    Chu, C
    Harper, JW
    Elledge, SJ
    [J]. SCIENCE, 2001, 294 (5540) : 173 - 177
  • [10] CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer
    Koh, MS
    Ittmann, M
    Kadmon, D
    Thompson, TC
    Leach, FS
    [J]. CANCER BIOLOGY & THERAPY, 2006, 5 (01) : 78 - 83